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1. Introduction 
The glutathione S-transferases are a family of 
enzymes that catalyse the conjugation of reduced glu- 
tathione (GSH) with a wide variety of electrophilic 
compounds [1 ]. In addition, the glutathione S-trans- 
ferases can act as non-specific binding proteins which 
facilitate the transport of a variety of tigands of both 
exogenous (e.g., bromosulphotbalein) a d endoge- 
nous (e.g., bilirubin) origin. Investigators studying 
hepatic binding proteins have termed the major bind- 
ing component as ligandin which subsequent s udies 
have identified as a glutathione S-transferase [2]. 
Thus the glutathione S-transferase/ligandin system 
makes a substantial contribution to the metabolism 
and elimination of a wide variety of reactive and 
toxic metabolites, mutagens and carcinogens. 
Deficiency of hepatic organic anion-binding pro- 
tein 0igandin/glutathione S-transferase) has been 
proposed as a possible cause of non-haemolytic 
unconjugated hyperbilirubinaemia in the new born 
[3]. That study suggested that relative deficiency of 
these acceptor proteins may be rate limiting in a 
transfer process. More recently, ligandinaemia has 
been reported in a number of inflammatory and neo- 
plastic liver diseases, including viral and chronic hepa- 
titis, cirrhosis and primary hepatocarcinoma [4-7]. 
These observations have prompted the suggestion that 
ligandinaemia may well provide a further means of 
evaluating liver damage and be of diagnostic value in 
cases of primary liver cell cancer [8,9]. 
Recent biochemical genetic studies utilizing elec- 
trophoretic techniques developed in this laboratory 
[10] have shown that the glutathione S-transferases in 
human liver are the product of 3 distinct structural 
loci [11]. Two of these loci, known as GST1 and 
GST2, are possibly the result of a gene duplication 
and are both highly polymorphic. The high degree of 
polymorphism and heterozygosity at these loci 
explains the multiple forms identified by ion-exchange 
chromatographic techniques [ 12]. Our investigations 
have demonstrated the existence of a null allele at the 
GST1 locus in some individuals [11 ]. This allele may 
result from gene deletion, as there is no evidence for 
the formation of an inactive product [11 ]. The phys- 
iological consequence of this null allele remains to be 
fully investigated, however, the data presented here 
demonstrate hat the total level of liver glutathione 
S-transferase activity is significantly diminished in 
individuals homozygous for this allele. 
3. Results and discussion 
Fig.l shows schematically the relative lectro- 
phoretic mobility of the products of the GST1 and 
GST2 loci and the observed allelic variation [11 ]. The 
products of these loci account for ahnost all the glu- 
tathione S-transferase activity in human liver. Homo- 
zygotes for the null allele at the GST~ locus (GST°/ 
GST °) fail to show any activity at the anodal end of 
the gel where GST1 products are normally observed. 
Products GST2 locus are always present and migrate 
towards the cathode under these conditions. The 
total glutathione S-transferase activity in liver 
extracts was determined spectrophotometrically 
using 1-chloro-2,4-dinitrobenzene and GSH as sub- 
strates [1] and is given in table 1. Individuals homo- 
zygous for tile null allele at the GST1 locus had a 
significantly lower (P < 0.01) total glutathione 
S4ransferase activity than a pooled group of individ- 
uals who expressed products of the GSTI or GST~ 
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Fig.1. Schematic representation f the glutathione S-transferase isozyme phenotypes observed in human liver. The possible geno- 
types are indicated beneath each phenotype. 
alleles. In addition, the variability of the homozygous 
null group was less than the variability of the pooled 
group, which would be expected to contain a propor- 
tion of individuals heterozygous for the null allele 
(GST~/GST °,GST~/GST °) in addition to individuals 
heterozygous and homozygous for the electropho- 
retically detectable alleles (GST]/GST~, GST]/GST], 
GST]/GST]). Although there is residual activity in 
samples with the GST null phenotype, due largely to 
Table 1 
Glutathione S-transferase activity in human liver 
GSTa Phenotype N Total activity a 
(mean _+ SD) 
Phenotype null 
(GST°/GST °) 18 0.66 -+ 0.279 
Electrophoretically detectable 
(GST',IGST',, GSTIIGST~, 
GST~/GST~, GSTI~/GST °, 
GST~/GST °) 18 1.01 _+ 0.415 
a Activity is expressed as #M conjugate formed, mg pro- 
tein -~ . min -~ at 25°C 
All liver samples were obtained at post-mortem examination 
and stored frozen at -20°C until electrophoretic phenotype 
and total glutathione S-transferase activity could be deter- 
mined 
the action of GST2 products and to a minor extent 
the GST3 products, the diminished total activity has 
several significant implications. 
If, as suggested [3], a relative deficiency of gluta- 
thione S-transferase (ligandin) is a significant factor in 
the aetiology of non-haemolytic unconjugated hyper- 
bilirubinaemia n the new born, then it is likely that 
individuals inheriting the null allele may be more 
likely to suffer this disorder during foetal develop- 
ment and in the neonatal period when production of 
ligandin is naturally at a low level [3]. 
These results also have significance in the evalua- 
tion of ligandinaemia associated with liver disease 
[4-9] .  The presence of a common null allele which 
significantly affects the level of glutathione S-trans- 
ferase/ligandin i  liver is likely to influence the degree 
of ligandinaemia which occurs in various hepatic dis- 
orders. This genetic factor, therefore, needs to be 
considered in further studies aimed at determining 
the clinical value of estimates in ligandinaemia. 
In addition, the partial deficiency of glutathione 
S-transferase occurring in individuals inheriting the 
null allele may place them at a relatively greater isk 
if they are exposed to elevated levels of certain elec- 
trophilic carcinogens. Further studies will be neces- 
sary to determine if the occurrence of the null allele 
and the diminished levels of glutathione S-transferase 
in some individuals are associated with an increased 
incidence of neoplastic disease. 
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